• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD10是侵袭性结直肠癌的可靠标志物吗?

Is CD10 a reliable marker of invasive colorectal cancer?

作者信息

Del Rio Paolo, Crafa Pellegrino, Papadia Cinzia, Benecchi Laura, Campanini Nicoletta, Sianesi Nicoletta, Montana Chiara Montana, Sianesi Mario

机构信息

Department of Surgical Science, General Surgery and Organ Transplantation, University Hospital of Parma, Parma, Italy.

出版信息

Ann Ital Chir. 2011 Jul-Aug;82(4):279-82.

PMID:21834477
Abstract

AIM

Previous studies reported that CD10 positive Colorectal Cancer Cells (CRC) characterized by deeply invasive neoplasia.

MATERIALS AND METHODS

We have examined 50 pts surgically treated for colorectal cancer on at least 5 years follow up. TNM, grading score and survival have been compared to CD10 expression.

RESULTS

Thirty-four out of fifty cases have been analyzed (18 males and 16 female) of whom nineteen were CD10 positive and fifteen were CD10 negative. The remaining 16 cases were droping out. No difference in survival rate between CD10 positive and negative in N0, N1, N2. No difference on survival rate and grading 1, 2, 3. We have then analyzed CD10 positive and CD10 negative cases, according to neoplasia grading, in patients with positive linphonodes N1 and N2. We showed a statistical difference between the CD10 positive/N2 (grading 1.66 +/- 0.5) and the CD10 negative/N2 (grading 3) (p < 0.005).

CONCLUSIONS

We can hypothesize that CD10 positive neoplasia display a more invasive behaviour, independently from the N score and the G score, compared to CD10 negative neoplasia.

摘要

目的

先前的研究报道,以深度浸润性肿瘤为特征的结直肠癌细胞(CRC)CD10呈阳性。

材料与方法

我们对50例接受手术治疗的结直肠癌患者进行了至少5年的随访。将TNM、分级评分和生存率与CD10表达进行了比较。

结果

分析了50例中的34例(18例男性和16例女性),其中19例CD10阳性,15例CD10阴性。其余16例失访。在N0、N1、N2中,CD10阳性和阴性患者的生存率无差异。在1级、2级、3级患者的生存率和分级方面也无差异。然后,我们根据肿瘤分级,对N1和N2阳性淋巴结患者的CD10阳性和CD10阴性病例进行了分析。我们发现CD10阳性/N2(分级1.66±0.5)和CD10阴性/N2(分级3)之间存在统计学差异(p<0.005)。

结论

我们可以推测,与CD10阴性肿瘤相比,CD10阳性肿瘤表现出更强的侵袭行为,与N评分和G评分无关。

相似文献

1
Is CD10 a reliable marker of invasive colorectal cancer?CD10是侵袭性结直肠癌的可靠标志物吗?
Ann Ital Chir. 2011 Jul-Aug;82(4):279-82.
2
CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.CD10 通过消除肝内蛋氨酸脑啡肽的抗肿瘤作用增强结直肠癌的转移。
Gut. 2010 Mar;59(3):348-56. doi: 10.1136/gut.2009.178376. Epub 2009 Oct 14.
3
[Tumour-cell dissociation as a prognostic marker in colorectal cancer].[肿瘤细胞解离作为结直肠癌的预后标志物]
Ugeskr Laeger. 2009 Sep 21;171(39):2812-7.
4
Flat adenoma-carcinoma sequence with high-malignancy potential as demonstrated by CD10 and beta-catenin expression: a different pathway from the polypoid adenoma-carcinoma sequence.CD10和β-连环蛋白表达显示具有高恶性潜能的扁平腺瘤-癌序列:一条与息肉状腺瘤-癌序列不同的途径。
Histopathology. 2008 Apr;52(5):569-77. doi: 10.1111/j.1365-2559.2008.02996.x.
5
A function for the integrin alpha6beta4 in the invasive properties of colorectal carcinoma cells.整合素α6β4在大肠癌细胞侵袭特性中的作用。
Cancer Res. 1996 Oct 15;56(20):4811-9.
6
p53 as an indicator of lymph node metastases in invasive early colorectal cancer.p53作为早期浸润性结直肠癌淋巴结转移的一个指标。
Anticancer Res. 2000 May-Jun;20(3B):2055-9.
7
CD10 expression in colorectal carcinoma correlates with liver metastasis.结直肠癌中CD10的表达与肝转移相关。
Dis Colon Rectum. 2005 Oct;48(10):1883-9. doi: 10.1007/s10350-005-0141-6.
8
APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.结直肠癌患者中APC、K-ras和p53基因突变:与临床病理特征及术后监测的相关性
Am Surg. 2005 Apr;71(4):336-43.
9
Predictive value of magnification chromoendoscopy for diagnosing invasive neoplasia in nonpolypoid colorectal lesions and stratifying patients for endoscopic resection or surgery.放大色素内镜检查对非息肉样结直肠病变浸润性肿瘤诊断及患者内镜切除或手术分层的预测价值
Endoscopy. 2006 May;38(5):470-6. doi: 10.1055/s-2006-925399.
10
Preoperative serum carbohydrate antigen 242 is a useful predictive and prognostic marker in colorectal cancer.术前血清糖类抗原242是结直肠癌中一种有用的预测和预后标志物。
Hepatogastroenterology. 2011 Mar-Apr;58(106):377-82.

引用本文的文献

1
CD10 Expression Correlates with Earlier Tumour Stages and Left-Sided Tumour Location in Colorectal Cancer but Has No Prognostic Impact in a European Cohort.CD10表达与结直肠癌的早期肿瘤分期及肿瘤位于左侧相关,但在欧洲队列中对预后无影响。
Cancers (Basel). 2024 Apr 11;16(8):1473. doi: 10.3390/cancers16081473.
2
Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.脐尿管癌和膀胱腺癌的生物标志物:综述补充自有数据。
Dis Markers. 2018 Mar 12;2018:7308168. doi: 10.1155/2018/7308168. eCollection 2018.
3
Prognostic significance of the combined expression of neutral endopeptidase and dipeptidyl peptidase IV in intrahepatic cholangiocarcinoma patients after surgery resection.
中性内肽酶和二肽基肽酶 IV 联合表达对肝内胆管癌患者术后的预后意义。
Onco Targets Ther. 2014 Feb 17;7:297-304. doi: 10.2147/OTT.S57355. eCollection 2014.
4
Synergistic relationship between dipeptidyl peptidase IV and neutral endopeptidase expression and the combined prognostic significance in osteosarcoma patients.二肽基肽酶 IV 和中性内肽酶表达的协同关系及其在骨肉瘤患者中的联合预后意义。
Med Oncol. 2013;30(3):608. doi: 10.1007/s12032-013-0608-6. Epub 2013 May 18.
5
Expression Profiling of Proliferation and Apoptotic Markers along the Adenoma-Carcinoma Sequence in Familial Adenomatous Polyposis Patients.家族性结肠腺瘤性息肉病患者腺瘤-癌序列中增殖和凋亡标志物的表达谱分析。
Gastroenterol Res Pract. 2013;2013:107534. doi: 10.1155/2013/107534. Epub 2013 Feb 13.